# Topical CBD for Musculoskeletal Pain

> **NCT05170451** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Virginia**

## Conditions studied

- Musculoskeletal Pain

## Interventions

- **DRUG:** CBD
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT05170451
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-01
- **Primary completion:** 2022-06
- **Final completion:** 2022-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Terminated due to hurdles of obtaining regulatory approval.
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05170451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05170451, "Topical CBD for Musculoskeletal Pain". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05170451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*